Targeting CD206+ macrophages disrupts the establishment of a key antitumor immune axis. #TIJC 3

WEBINAR Transdisciplinary Immunology Journal Club
Targeting CD206+ macrophages disrupts the establishment of a key antitumor immune axis, JExpMed. 
With Dr Marie ROBERT
Thursday, January 16, 2025 from 4:00 PM to 5:00 PM
REGISTRATION is REQUIRED to get the ZOOM link!

 

Revoir en Replay TIJC#1
JAK Inhibitors and Cancer: Friend or Foe? Par le Dr Samuel Bitoun, disponible ICI

Revoir en Replay TIJC#2
The type 2 cytokine Fc–IL-4 revitalizes exhausted CD8+ T cells against cancer, Nature 2024. Par le Dr François-Xavier Danlos, disponible ICI